Kangmei Pharma | 600518 - Equity Capital And Reserves

Stock Price
1.92
Daily Change
0.02 1.05%
Monthly
0%
Yearly
-16.16%
Q1 Forecast
1.86

Kangmei Pharma reported CNY7.22B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Avita Medical AUD -12.89M 17.39M Jun/2025
Cspc Pharmaceutical CNY 33.25B 984.93M Jun/2025
Dianthus Therapeutics USD 546.45M 243.38M Sep/2025
Genomma Lab Internacional MXN 11.01B 229.83M Sep/2025
Hypermarcas BRL 12.26B 260.73M Sep/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Jiangsu Hengrui CNY 59.5B 814.63M Sep/2025
Kangmei Pharma CNY 7.22B 504.3M Sep/2025
Moderna USD 9.33B 69M Sep/2025
Organon & Co USD 906M 173M Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Sh Fosun Pharma CNY 60.81B 12.74B Sep/2025
Tectonic Therapeutic USD 267.53M 16.24M Sep/2025
Viatris USD 15.22B 352.9M Sep/2025
Wuxi Apptec CNY 71.47B 11.56B Sep/2025
Xeris Pharmaceuticals USD -861K 18.44M Sep/2025
Zz Pientze Pharmaceu CNY 14.47B 173.2M Sep/2025